Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

Clinical trial NCT05557942 · TERMINATED

Trial details

NCT number: NCT05557942
Sponsor: Aerovate Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2022-11-02
Primary completion: 2024-08-08
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.